<DOC>
	<DOCNO>NCT00641186</DOCNO>
	<brief_summary>This clinical trial design evaluate safety potential efficacy Xyrem treatment excessive daytime sleepiness ( EDS ) nocturnal sleep disturbance patient mild moderate Parkinson 's Disease ( PD ) .</brief_summary>
	<brief_title>Trial Xyrem Excessive Daytime Sleepiness Sleep Disturbance Parkinson 's Disease ( PD )</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dyssomnias</mesh_term>
	<mesh_term>Sleep Wake Disorders</mesh_term>
	<mesh_term>Parasomnias</mesh_term>
	<mesh_term>Sodium Oxybate</mesh_term>
	<criteria>Male female diagnosis idiopathic PD . Age 30 75 , inclusive . Hoehn &amp; Yahr Stage 1.5 4.0 practically define `` OFF '' . History &gt; 2 month excessive daytime sleepiness confirm baseline/screening Epworth Sleepiness Scale score &gt; 10 . History &gt; 2 month nocturnal sleep disturbance consist insomnia , fragment sleep and/or nonrestorative sleep . Folstein MiniMental State Exam score &gt; 24 . Birth control sexually active woman childbearing potential ( e.g . abstinence , hormonal contraception , barrier method , intrauterine device ) . Evidence personally sign date informed consent form document indicate subject ( legally acceptable representative ) inform pertinent aspect trial . Subjects willing able comply schedule visit , treatment plan , study procedure . Stable dose medication , define change dose regimen medication least 3 month prior Screen Visit . Known idiopathic sleep pathology : sleep apnea narcolepsy . Serious comorbid disease Atypical parkinsonism ( e.g. , Parkinson `` plus '' syndrome , secondary Parkinson 's syndrome ) . Significant neurological symptom account PD . Significant psychiatric symptom dementia . Sexually active woman childbearing potential without adequate form birth control . Pregnancy lactation . Minimental status examination &lt; 25 . Participation another clinical trial another investigational agent device within previous 60 day . Current abuse alcohol drug . Active prior malignancy cutaneous basal cell carcinoma situ carcinoma uterine cervix . Known hypersensitivity sodium oxybate constituent product . Any medical condition contraindication use sodium oxybate significant hepatic impairment . Patients treat sedative hypnotic agent central nervous system ( CNS ) depressant . Subjects take warfarin . Patients succinic semialdehyde dehydrogenase deficiency . Subjects , opinion investigator , able comply requirement study . Any condition , investigator 's opinion , would cause significant hazard subject .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2009</verification_date>
	<keyword>excessive daytime somnolence</keyword>
	<keyword>Parkinson disease</keyword>
	<keyword>sleep disturbance</keyword>
</DOC>